Farxiga — Nutrient Associations & Health Patterns
Also known as: Dapagliflozin (Farxiga)
Drug Class: SGLT2 inhibitor (Diabetes medication)
Farxiga is a SGLT2 inhibitor (Diabetes medication) that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Farxiga.
Reported Nutrient Associations for Farxiga
Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.
- Magnesium
- Phosphorus
- Vitamin B1
- Sodium
Common Side Effects of Farxiga
- Urinary tract infections
- Genital yeast infections
- Increased urination
- Low blood sugar
- Dehydration
- Ketoacidosis risk
Key Drug Interactions — Farxiga
Farxiga has 5 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Insulin
- Sulfonylureas
- Diuretics
- ACE inhibitors
- ARBs
Frequently Asked Questions
What nutrient associations are reported for Farxiga?
Farxiga has reported nutrient associations involving Magnesium, Phosphorus, Vitamin B1, Sodium in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.
Which nutrient relationships are mapped for Farxiga?
WePattern maps reported associations involving: Magnesium, Phosphorus, Vitamin B1, Sodium. The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.
What are the side effects of Farxiga?
Common side effects associated with Farxiga include: Urinary tract infections; Genital yeast infections; Increased urination; Low blood sugar; Dehydration.